Ali Roghanian

4PUBLICATIONS
4CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 22, 2025
CD40L and IL-4 suppress NK cell-mediated antibody-dependent cellular cytotoxicity through the HLA-E:NKG2A axis.

Lara V Graham, Ludmila Horehajova, Marco V Haselager

|May 19, 2025
Therapeutic targeting of tumour-associated macrophage receptors.

Rosa Gomes Alves Martins, Mehmet M Tekin, Mark S Cragg

|Mar 16, 2025
FcγRIIB (CD32B) antibodies enhance immune responses through activating FcγRs.

Alexander P Simpson, Robert J Oldham, Kerry L Cox

|Aug 28, 2019
Cyclophosphamide Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression.

Ali Roghanian, Guangan Hu, Christopher Fraser

Pageof 1

Frequent Collaborators

2 joint publications

Mark S Cragg

1 joint publications

Margaret Ashton-Key

1 joint publications

Lara V Graham

1 joint publications

Matthew D Blunt